Bamco Inc Zai Lab LTD Transaction History

Bamco Inc

$37.5 Billion
Q4 2024

A detailed history of Bamco Inc transactions in Zai Lab LTD stock. As of the latest transaction made, Bamco Inc holds 1,909,088 shares of ZLAB stock, worth $59.2 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,909,088

Previous 1,906,520 0.13%

Holding current value

$59.2 Million

Previous $46 Million 8.64%

% of portfolio

0.13%

Previous 0.13%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$24.61 - $33.18 $63,198 - $85,206	2,568 Added 0.13%	1,909,088 $50 Million
Q3 2024 Nov 14, 2024	BUY	$16.25 - $24.14 $1.85 Million - $2.75 Million	113,869 Added 6.35%	1,906,520 $46 Million
Q2 2024 Aug 14, 2024	BUY	$13.72 - $21.55 $2.65 Million - $4.15 Million	192,786 Added 12.05%	1,792,651 $31.1 Million
Q1 2024 May 15, 2024	BUY	$15.95 - $26.8 $1.74 Million - $2.92 Million	108,991 Added 7.31%	1,599,865 $25.6 Million
Q4 2023 Feb 14, 2024	SELL	$22.97 - $30.58 $2.03 Million - $2.71 Million	-88,475 Reduced 5.6%	1,490,874 $40.7 Million
Q3 2023 Nov 14, 2023	BUY	$22.72 - $31.49 $1.53 Million - $2.12 Million	67,288 Added 4.45%	1,579,349 $38.4 Million
Q2 2023 Aug 14, 2023	BUY	$25.3 - $39.67 $2.2 Million - $3.45 Million	86,847 Added 6.09%	1,512,061 $41.9 Million
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $2.16 Million - $3.43 Million	71,399 Added 5.27%	1,425,214 $47.4 Million
Q4 2022 Feb 14, 2023	SELL	$22.28 - $38.71 $490,204 - $851,697	-22,002 Reduced 1.6%	1,353,815 $41.6 Million
Q3 2022 Nov 14, 2022	SELL	$34.2 - $51.69 $12.1 Million - $18.3 Million	-353,144 Reduced 20.43%	1,375,817 $47.1 Million
Q2 2022 Aug 15, 2022	SELL	$23.14 - $49.68 $786,065 - $1.69 Million	-33,970 Reduced 1.93%	1,728,961 $60 Million
Q1 2022 May 13, 2022	BUY	$27.77 - $64.4 $5.67 Million - $13.2 Million	204,207 Added 13.1%	1,762,931 $77.5 Million
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $747,243 - $1.43 Million	13,611 Added 0.88%	1,558,724 $98 Million
Q3 2021 Nov 12, 2021	SELL	$105.0 - $178.37 $22.3 Million - $37.9 Million	-212,546 Reduced 12.09%	1,545,113 $163 Million
Q2 2021 Aug 13, 2021	SELL	$125.11 - $180.0 $8.13 Million - $11.7 Million	-65,019 Reduced 3.57%	1,757,659 $311 Million
Q1 2021 May 19, 2021	SELL	$126.27 - $191.71 $28.2 Million - $42.8 Million	-223,477 Reduced 10.92%	1,822,678 $243 Million
Q4 2020 Feb 12, 2021	BUY	$81.94 - $135.34 $1.88 Million - $3.11 Million	22,963 Added 1.13%	2,046,155 $277 Million
Q3 2020 Nov 13, 2020	SELL	$73.3 - $89.48 $1.18 Million - $1.44 Million	-16,131 Reduced 0.79%	2,023,192 $168 Million
Q2 2020 Aug 14, 2020	SELL	$48.82 - $82.53 $9.11 Million - $15.4 Million	-186,572 Reduced 8.38%	2,039,323 $167 Million
Q1 2020 May 15, 2020	BUY	$39.1 - $62.9 $1.07 Million - $1.72 Million	27,405 Added 1.25%	2,225,895 $115 Million
Q4 2019 Feb 18, 2020	SELL	$29.79 - $43.06 $696,758 - $1.01 Million	-23,389 Reduced 1.05%	2,198,490 $91.4 Million
Q3 2019 Nov 14, 2019	BUY	$30.47 - $37.65 $684,386 - $845,656	22,461 Added 1.02%	2,221,879 $71.9 Million
Q2 2019 Aug 15, 2019	BUY	$25.73 - $35.79 $5.18 Million - $7.21 Million	201,326 Added 10.08%	2,199,418 $76.7 Million
Q1 2019 May 15, 2019	BUY	$21.71 - $31.54 $522,755 - $759,451	24,079 Added 1.22%	1,998,092 $59 Million
Q4 2018 Feb 14, 2019	BUY	$14.95 - $24.72 $1.1 Million - $1.82 Million	73,582 Added 3.87%	1,974,013 $45.8 Million
Q3 2018 Nov 14, 2018	BUY	$17.8 - $25.35 $32.2 Million - $45.8 Million	1,807,990 Added 1955.83%	1,900,431 $37 Million
Q2 2018 Aug 14, 2018	BUY	$18.0 - $25.01 $439,938 - $611,269	24,441 Added 35.94%	92,441 $2.15 Million
Q1 2018 May 09, 2018	BUY	$20.05 - $26.96 $1.36 Million - $1.83 Million	68,000 New	68,000 $1.45 Million

Others Institutions Holding ZLAB

# of Institutions

146

Shares Held

53M

Call Options Held

103K

Put Options Held

439K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.03B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.

Account